Adverse Events Costs Associated With Erlotinib Or Afatinib In Non-Small Cell Lung Cancer (Nsclc) Patients With Egfr Mutation-Positive Tumours
Abstract
Authors
D Isla J De Castro O Juan Vidal S Grau J Orofino R Gordo C Rubio-Terrés D Rubio-Rodríguez